Description

They are based on the antibacterial activity and pharmacokinetic characteristics of azithromycin. They take into account both the clinical studies conducted on this medicinal product and its place in the range of currently available antibacterial products. They are limited to infections due to germs defined as sensitive: – documented angina due to beta-haemolytic streptococcus A, as an alternative to treatment with beta-lactams, particularly when this cannot be used. – superinfections of acute bronchitis, – exacerbations of chronic bronchitis, – stomatological infections. Official recommendations on the appropriate use of antibacterials should be taken into account.